Endocrinology
Page 1 • 2 itemsGain critical insights into global endocrinology drug development, clinical trials, regulatory approvals, and market trends. Inform your pharma strategy.
Neurocrine Biosciences CRENESSITY Shows Sustained Benefits in Two-Year Pediatric CAH Study
CRENESSITY (crinecerfont) demonstrates durable hormone control and reduced glucocorticoid exposure in pediatric congenital adrenal hyperplasia patients.
FDA Encourages Testosterone Therapy Expansion for Low Libido in Men with Hypogonadism
FDA takes initial step to advance testosterone replacement therapy for low libido in men with idiopathic hypogonadism, encouraging sponsors to pursue new indication.